Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Racecadotril for Organ Injury in Sepsis Patients
NCT07454421Phase 2Enrolling by invitation
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- May 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of racecadotril in sepsis (2 arms), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoint: Sequential Organ Failure Assessment-2 at Day 5. Started May 2026; status: enrolling by invitation.
02
Drugs
racecadotril
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT07454421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07454421.